High flow ventilators market seen climbing to $64.47 billion by 2030

The Business Research Company says the global high flow ventilators market is expanding as COPD and other respiratory conditions drive demand for advanced breathing support. The market is projected to rise from $36.77 billion in 2025 to $64.47 billion by 2030, with North America leading and Asia-Pacific set to grow fastest.

Why it matters: - High flow ventilators are becoming more important as respiratory illness rates rise and hospitals, home-care providers and monitoring services look for better oxygen delivery options. - The market’s projected jump to $64.47 billion by 2030 signals sustained demand for non-invasive respiratory support and portable care tools.

What happened: - The Business Research Company released a market study on the global high flow ventilators market on August 10, 2026. - The report estimates the market will grow from $36.77 billion in 2025 to $40.97 billion in 2026. - The study projects the market will reach $64.47 billion by 2030. - North America was the largest regional market in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the next several years. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - High flow ventilators deliver humidified oxygen at higher flow rates than traditional oxygen therapy systems. - The devices are used for patients with COPD and other lung-related conditions. - Higher oxygen delivery helps improve oxygenation and reduce breathing effort. - The study links recent growth to more respiratory conditions, expanded intensive care infrastructure, more COPD-related hospital admissions, ventilator technology gains and wider access to advanced respiratory consumables. - The report says future growth will be supported by more home-based respiratory care, more investment in portable ventilation devices, expansion of tele-respiratory monitoring, earlier respiratory intervention and ongoing oxygen-delivery innovation. - Key forecast-period trends include wider adoption of high flow oxygen therapy, more demand for non-invasive ventilation support, greater use of portable ventilator units, growth in remote respiratory monitoring and more emphasis on patient comfort and humidification. - The 2026 edition of the market reports adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - COPD is the clearest demand driver in the release because the disease creates ongoing pressure on healthcare systems and requires repeated breathing support during flare-ups. - The shift toward portable devices, tele-monitoring and home care suggests the market is moving beyond hospital-only use toward longer-term and more distributed respiratory care. - The regional outlook points to mature adoption in North America and faster expansion in Asia-Pacific, where healthcare investment and patient counts are rising.

What's next: - The market is expected to keep growing through 2030 as respiratory care moves toward earlier intervention, more portability and more remote monitoring. - The company’s updated report tools are aimed at helping buyers and investors compare market attractiveness, forecast demand and identify high-opportunity regions and technologies.

The bottom line: - High flow ventilators are moving from a specialized hospital tool to a broader respiratory care category, and the market study points to years of double-digit growth ahead.